Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInduction Heal. Regulatory News (INHC)

  • This share is currently suspended. It was suspended at a price of 9.75
  • There is currently no data for INHC

AGM Statement

4 Nov 2021 07:00

RNS Number : 2799R
Induction Healthcare Group PLC
04 November 2021
 

Induction Healthcare Group PLC

("Induction", the "Company", or the "Group")

 

AGM Statement

£11.2m contracted revenues already secured for the current financial year

 

Induction (AIM: INHC), a leading virtual care platform driving digital transformation of healthcare systems worldwide, provides an update to shareholders ahead of its Annual General Meeting ('AGM') being held today at 50 Liverpool Street, London EC2M 7PY at 9.00 am.

 

At the meeting James Balmain, Chief Executive Officer, will make the following statement:

 

"I am very pleased to welcome shareholders to our Annual General Meeting and to provide them with a short update on the strong performance we have experienced in the first half of the new financial year, underpinning our expectations for the full year.

 

"As highlighted in our recent Final Results statement we continue to see growing demand for our flexible care platforms. As health systems around the world continue to execute their pandemic recovery plans, we're seeing rapidly increasing levels of investment from both local providers and regional care systems. The acquisition of Attend Anywhere in June further enhances our leading market position and gives us comprehensive coverage of the secondary care patient pathway by allowing us to offer appointment booking, remote data capture and the full range of telephone and video consultations.

 

"The Group currently has £11.2m of contracted revenues secured for the financial year ending 31 March 2022, and the integration and realisation of cost synergies with Attend Anywhere are proceeding better than expected and this is providing the Board with confidence that we are in line to meet market expectations for the full year.

 

"We go into the remainder of the financial year with a strong pipeline of potential new contracts and renewals, and we continue to see a substantial increase in patient and clinical users. We are very excited about the prospects for the Company and look forward to updating shareholders as our strong sales momentum continues."

 

 

ENQUIRIES

 

Induction

James Balmain, Chief Executive Officer

Dr Hugo Stephenson, Group Executive Director

Via Walbrook PR Ltd: induction@walbrookpr.com

Singer Capital Markets (Nominated Adviser and Broker)

+44 (0) 20 7496 3000

Philip Davies / Kailey Aliyar

Walbrook PR Ltd 

induction@walbrookpr.com

Paul McManus / Alice Woodings

Mob: +44(0)7980 541 893 / +44 (0)7407 804 654

 

About Induction - www.inductionhealthcare.com

 

Induction (AIM: INHC) is a leading virtual care platform driving digital transformation of healthcare systems worldwide. Induction solutions enhance the investments hospitals have made and lay the foundation for their future. Our products can enable information sharing between busy doctors, alleviate operational burdens on hospitals or put patients in better control of their care, all while ensuring the highest standards of clinical safety and information security. We unchain staff and patients from the limitations of paper-based and desktop systems, creating substantial time and cost efficiencies.

 

More than 225,000 hospital doctors across multiple territories, including the UK, Ireland, Australia and South Africa, as well as a rapidly growing number of more than 300,000 UK patients, choose Induction solutions.

 

Induction Switch is the number one healthcare collaboration app in the UK, used by the majority of hospital doctors within the NHS. The app helps to increase productivity and enhance communication by securely sharing phone numbers and bleeps, bookmarks, documents and messages in a clinical setting.

 

Induction Guidance provides medical organisations, including most hospital trusts within the NHS, with the ability to collaboratively create, edit, and publish their own local medical guidelines in a secure and locally administrated environment. This increases knowledge of, and adherence to, guidance.

 

Induction Zesty is a market-leading digital platform for patients visiting hospitals. The platform allows patients to book and access their appointments, read their clinical letters, store a copy of their clinical record and provide data to their care teams remotely. It is not just a compelling patient experience, but also delivers significant cost benefits to hospitals.

 

Induction Attend Anywhere is the UK market leader in secondary care video consultations. It helps hospitals, health systems and other customers offer video consultations to patients and service users as a normal part of day-to-day clinical activity. Our vision is for video consultations to improve lives and help address social, access, equity and sustainability challenges by allowing healthcare providers to determine how and when they see a patient based on each individual case: in-person, via video or on the telephone.

 

Induction HealthStream is a proprietary data integration platform that reads and writes patient demographic, appointment and clinical record data between a growing number of hospital EHR systems and the Induction platforms. This connectivity between stakeholders and legacy IT systems adds substantial value to pre-existing health IT investment and allows large-scale adoption of Induction app-based services.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMFSFFUDEFSESF
Date   Source Headline
15th Mar 20217:00 amRNSNHS contract wins for Induction Booking
10th Mar 20217:00 amRNS1m UK hospital appointments booked since Oct 2020
8th Mar 20217:00 amRNSNew public sector contracts for Induction Booking
4th Mar 20217:00 amRNSChange of Adviser
19th Jan 20218:00 amRNSDirectorate Change
13th Jan 20217:00 amRNSRFL selects Induction to deliver patient portal
10th Dec 20207:00 amRNSHalf year results
27th Oct 20207:00 amRNSInduction aids rollout of Health Records on iPhone
12th Oct 20207:00 amRNSStrategic Collaboration Between Cerner & Induction
21st Sep 202010:24 amRNSResult of AGM
1st Sep 20207:00 amRNSInduction: Horizon achieves earn-out target
28th Aug 20207:00 amRNSNamed Supplier on NHSX Procurement Framework
6th Aug 202010:00 amRNSAnnual Report and Accounts and Notice of AGM
6th Aug 20207:00 amRNSFull year results for the year ended 31 March 2020
29th Jul 20207:00 amRNSNotice of Results
16th Jul 20201:05 pmRNSHoldings in Company
9th Jun 20205:58 pmRNSHolding(s) in Company
9th Jun 20208:34 amRNSDirector/PDMR Shareholding
9th Jun 20208:09 amRNSHolding(s) in Company
9th Jun 20208:09 amRNSHolding(s) in Company
9th Jun 20208:09 amRNSHolding(s) in Company
9th Jun 20208:09 amRNSHolding(s) in Company
9th Jun 20208:09 amRNSHolding(s) in Company
5th Jun 20209:57 amRNSResult of General Meeting
20th May 20205:06 pmRNSPublication of Circular
19th May 20207:00 amRNSProposed acquisition of Zesty Limited
16th Apr 20207:00 amRNSMarket Update
2nd Mar 20207:00 amRNSBoard and management changes
28th Nov 20197:00 amRNSHalf-year Results
6th Nov 20197:00 amRNSAcquisition of Horizon Strategic Partners Limited
24th Oct 201910:00 amRNSAppointment of acting Head of Product/Development
17th Oct 20194:57 pmRNSHolding(s) in Company
15th Oct 20193:59 pmRNSHolding(s) in Company
19th Sep 20193:07 pmRNSResult of AGM
30th Aug 201910:18 amRNSAnnual Report and Accounts and Notice of AGM
16th Aug 20197:00 amRNSDirectorate Change
29th Jul 20197:00 amRNSPreliminary Results
19th Jul 20197:00 amRNSBoard appointment
23rd May 201911:10 amRNSHoldings in Company
22nd May 20198:00 amRNSAdmission to trading on AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.